NCT00894946
Unknown
Phase 3
The in Vitro Fertilisation - Lipiodol Uterine Bathing Effect Study
University of Auckland, New Zealand1 site in 1 country350 target enrollmentMay 2009
Overview
- Phase
- Phase 3
- Intervention
- Not specified
- Conditions
- Endometriosis
- Sponsor
- University of Auckland, New Zealand
- Enrollment
- 350
- Locations
- 1
- Primary Endpoint
- Live birth
- Last Updated
- 16 years ago
Overview
Brief Summary
The hypothesis of this study is that Lipiodol uterine bathing improves the success rate of in vitro fertilization (IVF) for women with endometriosis or recurrent IVF implantation failure.
Investigators
Eligibility Criteria
Inclusion Criteria
- •12 or more months infertility
- •Age 18 to 39
- •Endometriosis or recurrent IVF implantation failure
- •Patent fallopian tubes
Exclusion Criteria
- •Iodine allergy
- •Blocked fallopian tube or tubes
Outcomes
Primary Outcomes
Live birth
Time Frame: 12 months post-randomization
Secondary Outcomes
- Clinical pregnancy(3 months post-randomization)
- Adverse events(3 & 12 months post-randomization)
Study Sites (1)
Loading locations...
Similar Trials
Unknown
Phase 3
Endometrial Effects of LipiodolFemale InfertilityNCT03542331Universitair Ziekenhuis Brussel20
Withdrawn
Phase 4
Does Letrozole Improve the Outcomes and/or Reduce the Cost of IVF-ET Cycles?InfertilityNCT00804960Center for Human Reproduction
Not yet recruiting
Not Applicable
Lipiodol Prior to FET (LIFE)IVFFrozen Embryo TransferHysterosalpingographyNCT06563908Mỹ Đức Hospital784
Active, not recruiting
Phase 1
Intralipid treatment and infertilityInfertility conditions that required IVF treatment Male infertility Endometrosis PCOS uNEXPLAINED INFERTILITY Tubal damageTherapeutic area: Diseases [C] - Female diseases of the urinary and reproductive systems and pregancy complications [C13]EUCTR2017-002936-17-SEivio Falun2,200
Completed
Not Applicable
The effectiveness of intrauterine insemination in subfertile couples with an isolated cervical factor: a randomised controlled trial.subfertilityNL-OMON26297OFO-projectt.a.v. B.W. MolAcademic Medical CenterCenter of Reporductive medicine, H4-213Postbus 226601100 DD AmsterdamPhone: 0031205663857Fax: 0031206963489e-mail: ofoproject@amc.uva.nl or b.mol1@chello.nl100